CINXE.COM

<!DOCTYPE html><html lang="en-US"><head><title>Just a moment...</title><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><meta http-equiv="X-UA-Compatible" content="IE=Edge"><meta name="robots" content="noindex,nofollow"><meta name="viewport" content="width=device-width,initial-scale=1"><style>*{box-sizing:border-box;margin:0;padding:0}html{line-height:1.15;-webkit-text-size-adjust:100%;color:#313131;font-family:system-ui,-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Helvetica Neue,Arial,Noto Sans,sans-serif,Apple Color Emoji,Segoe UI Emoji,Segoe UI Symbol,Noto Color Emoji}body{display:flex;flex-direction:column;height:100vh;min-height:100vh}.main-content{margin:8rem auto;max-width:60rem;padding-left:1.5rem}@media (width <= 720px){.main-content{margin-top:4rem}}.h2{font-size:1.5rem;font-weight:500;line-height:2.25rem}@media (width <= 720px){.h2{font-size:1.25rem;line-height:1.5rem}}#challenge-error-text{background-image:url(data:image/svg+xml;base64,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);background-repeat:no-repeat;background-size:contain;padding-left:34px}@media (prefers-color-scheme:dark){body{background-color:#222;color:#d9d9d9}}</style><meta http-equiv="refresh" content="390"></head><body class="no-js"><div class="main-wrapper" role="main"><div class="main-content"><noscript><div class="h2"><span id="challenge-error-text">Enable JavaScript and cookies to continue</span></div></noscript></div></div><script>(function(){window._cf_chl_opt={cvId: '3',cZone: "portlandpress.com",cType: 'managed',cRay: '8e946af9fe0d919c',cH: 'gW61W9fOOOPd.Dxv5LfY5GCn8nGT_NvKBQXHb77zhMs-1732734621-1.2.1.1-JPnXbfETo.KGGIrYfg__9QeSNUSoufQtzT.oM0UyxiSndL0OKcAezhEW5iA3W45j',cUPMDTk: "\/biochemj\/article\/70\/4\/660\/51446\/Toxopyrimidine-phosphate-as-an-inhibitor-of?__cf_chl_tk=GJyPxW8AsClZn3FJureRJ47W2ULImRwU1ri46ctK9RQ-1732734621-1.0.1.1-8ZItR1ZVOSjdB4AO_SxsshheO298y1htfiQ0988Ouqg",cFPWv: 'b',cITimeS: '1732734621',cTTimeMs: '1000',cMTimeMs: '390000',cTplC: 0,cTplV: 5,cTplB: 'cf',cK: "",fa: "\/biochemj\/article\/70\/4\/660\/51446\/Toxopyrimidine-phosphate-as-an-inhibitor-of?__cf_chl_f_tk=GJyPxW8AsClZn3FJureRJ47W2ULImRwU1ri46ctK9RQ-1732734621-1.0.1.1-8ZItR1ZVOSjdB4AO_SxsshheO298y1htfiQ0988Ouqg",md: "lNBMyxIEZ6_.uEJygrO7Zqqzbio4SdHrE6x8lSTeIPY-1732734621-1.2.1.1-ZT_gWlmyyYpu8lX3Z5QxpJK5.8SOg1JFPqBP9X0ZMMq5f6jfMPWXQrmLawwPdxAiYeuKHr2nzM2GADeKNjzfcIJK5gBIlHr5pYRuyXb6hKhSFuRfVhfFoau3HCgDpZnJB.mbJgEGcX9SiE4jK55.ATg7ZQxXOU3ZRrAP00uOr6K7CCCQkAx3B2Tffu6T_FuyXyKJd4BLl16uGIegcNInNWy6DVUhhjGmI7yd7A1Xvd7b4lrFd_mSKlMd81TjhCuQA4uvHwhetnioqkHl90lPbq2uKi.EwDmpu9T_bRj4G6CexGcmNZnIwoOMnoDABZuNTEFRwT_3OomgPN7xBI_F83xMfIg7A5gioF6V87WahJNSg7txWfA_wp637tetW_pU.A2NzoggMhOhZHzWaIOWVSC_Dk7hi_3SIIuei2Tnv7OXPoCAfyRCTEZ4T5JwuE6YH72C6dg0LxKHK3SJqSwGN5uPsId7hF2p_enw_PFj_y595vS6.UUuTceTxcIwCbTY7dlXZWRFjgSfs_ORObpc4fq1wv7OhbIHM9lUqO.6ZmS9hlOM.QMh.mcjD2cB9mru4WQlRjhVDXixEKj138SmX3Zhm5hVxA1dWIvL.avOBZU0ixor0cilx61QmNfT5.08W38gnKzQQQvkfCclxATlVIQ8sD9rz1uMsjCIfFSpM9UnNgNa7t7PYWVXmZJr1IiCuQth4n1U7xYZQWO9HO6DSg6.oLG99OTTYIbnD7qNai9NOVICrGHkprBYbLnWElGiQQeHPE3He6sQDjxKrn4G_pdv8eelVDguUMRFDaN3vX7e2sfHLzDzSg9sOJwiSZN_4956xq4p3GCVMSACe6Zo1p9gkUgX3yaSoiqoKYS50IUsd1OyM.nUQMdrM4UKdQiA_YnJYNGr7QHt5RteAscMPsJ_x6UAfV7UGzjnkSReMBPD3nglthf6.OnmxXxz0XtBYA4Y_AX9jT3doK45kf7HctpC8BhVknGZ85r.03qlq69oWuBi3Q4tsEIYUKFTUfkxxAll4tcVE986cmru5lFE50pTisL1ZemRcvRFi3tW732N3sAIwSmyirfE66Q0HpDFXYt2sV5CVyM2jOAgdD2AP9nZMwhbd5VQpu5GkfOTFt1fMlJdqtoKiaYQVl6rlVLVkEA32rY70FPlS93a586mIFmdfzOPEjJkUMQkG2p0aUxWFg9VEWvsZbCUscxb99O4Qv4C6sxagi.sPAC4bOLZN_geeVF0ZF.6PlOwEUvVxsnwnjSLMfQtbJq5VLGp3otkskD4a7oGrOcts513PRXmtr9uSOzUJ9Ff2kXRXIrCzPIbbyfqTCi_YntKr1MFefiwq9b5IRs8vML_nfZX59grkeMaXGN.OagrRYRrhh4LdBLfcOtbskHadEiAOLH0zGXU4eMEdtLsiWYY4Ze_FICoZI4rgmF.oOsuXv_ltFcJu3WSAVVvik84iDw2Klqpr1.robWryoLDh0zCsnTek9gIsHqgJ6Dc8OSvYtyv7FAHIEE0hJCiTyqvk1WYKSUyjd0tZW8pHOC9lgzTfg_3LMB4VS9lLxBkN5Ew4VKEZenZsSScaXXE8zm.ao2Qqf1dXdxGFzJHe8nYH6ePLN3q13KpYt0473MyEClHx_NvtOH4Bzc.Hc.lzE_bah6gWdOz93e46PNKV01sGhj8eB_r.Eg4YDl3mF0veXq5A2KyWZqsPOnpooNuKY_fHeqPJAbXj2oj0MJqqIEmbzq0G599B4nWuUupjBCRg0Gl9OaDtBE9nA8WlSdPd5eqlyXPnkZVKDVFjk1axVwP_cZqT1VZfAEnd0RXFwnGbJnaEjNwhxHUqSJWiugf8sCZsC2SULmSRBg9DH6eETEr84nsHCa5I6BezErAaGO7hssnj1PB7AwJY0COuSATd9E5v8FJJRYCyFhRDr.jeC15hdi.UE5jEMrPeIZ5q56KBVz0tgXURCKXvh0fcugbZKrSX.gzPoKPrE59ac8HZDmwyeIvDyqGcthamMq5PICb0Jj7yqBDXAL7P.JjoKXi6ol.zt9i3CfNcluOMvWHvIaA6NPvKzXG898Zon6R5AxHN9EEFIeSMrsE9_qhM1UTbuu9fn72.15PO.c.3MdbvLj1BPatBxGRpnMH3aXu5BWLPgHS57WvdrgWG6LLQCd0w_W22HceUKOH0ef0WW.FLTivlfGHi1sCd0GErAMm47QCM4t1SG7ksz0n0zz5vWYo0KUn8eK1U4QlfKBI3bC7i9GamP4ZDWMWz.WfZSVj2KeZlaBEzbJA9I8_RIzPpSWKRCvo13.xVGgUTwfUJ7Gzfc9OnQ1HwcSAaP75DbYpsiPCpPkBKuWWJIL20_7SkwzMEqS1zc_Wx0cbhQIfzsYhvUp3jb7apkYRtB7h_LBOyaW6cBC2OenYeLQLongRxPb1o8orbnj7G1bgd4mb71F64r9TDI5p4zazs7BjdJDcTsvRJpy6r6mOw4WnNaMmKkDImabqpsy3ZG09opqOvzGSZjUST4FZBnJU5AbXYoWTxqSbwXy_xCIA5hgnI1f73CWL3jCrfpT72r3o_ZxLg8CkXJud_6wktllfhQk4jjwpvOvAHSNLinYyAICiyE__XRM_C8XXFUjYMl2U3KNgQkPTpZxaui8sQC.KdnsOAST7VgB5Xfl8RhZOihET7w6dnNI_N3Z4DDB2Va4nlzI8Q1lgfeWFzKI1nWRx9d_Vz.slafxo2weZFFttNnmKQ4PatR79mzNziZNqooXXOIJV0a2XsNx5oi_4jaE79diWTD.NJmtLAV4CU2Is109GBfqcNqHYFfGH7Vo.627SUt7r_zeGSTdrSRV2yFoVVvowOeXII4NBlD8Yl4NsPGAT2s9mj.H3bP8ftmi6VSoy7ywOHFRbeW_Adot3k.lZ0AgziXIWGSX7ZGYGLbkzdB1XbxbN12LFOhPhRXuVYBpmggcu735Vgt8k.DvDrubfqYUp3l1Pl4bJlTJkH.ILXjdtce2MBEff2RkU46pHPQeh4lL_Lb7IHtHP8GV2Z7jndkJyHxPSIcBnEzPkXJnpW3fmdk9feTtXDA6lMqqk2B1NebelG0LnpZG_8FRluS2sQjKpRL1R9KL09SlPPHNQyogbfwE",mdrd: "guNiT9rbGFEGkxiu5rluUq.bJMoR1giStvK.gjIr5KA-1732734621-1.2.1.1-waMFYbDhaAlY4AmY5i3AENftfu8gM1vaTM_Wc71CzRT2jvsE7camY_sgr_IONUlcIg8muFuyUgIkrJwsTaTSLrtd.1Kw8d1KB3V84uOg26v3gPNzw2o_oiyFPCM1ht39tHYVzLu8Ww0.o7lMCf9kave5jv9uBO0LlLUgd8XM_y6DN1nByQT9d7v4A3cf4LLUSMKlZUX74CX92K8TAkRqfTod4Y8q9_jpT3OJDVzZCTTKnYeQQ.XNz8VQfZ8wxv_8wKVDW8.RKS3G78Xskap.vemhnADus0s7UGI0RN7AYLIF9S7FZysOTYvv4zVzO171lRIVLLhU3G9vUE2Ld9m18IH_ybn.lyCkAa09_ld5X00vmXzbax9jDMGZB6.WtUZMEgHkuUXCOXG4wF5EhgE7fUenjVixGzSDotGJmDVUNPpBH10_.f1CfsUj0wRRrn_RSdVht8J7H8Yg6lBBRIaKfge0R6mKL7Z__o98DB1scKwXhMXyVit7w2u6_QK49VWh5TsxDiH73bw.nyAAQ_.HrMkpgmHBeWF70tvOhp8G_SeJGxcxw.okZm3y2dM7U3CkEMy.wrB3BBMQESqTTi_39.ql4Xob5.9HLUrT7KydlVX.x5hJB3.cuxgAwhcnC4rfR6WN0DFyxdBkSipVtBMKQD_LNubI6RbPkfzf2exBvP.X2c.k_j64YLPrXCQyyWG8rCiXA.sq.dy4nZ8aVEg7fwjyHHJydnK8v7lmr7soXOuwFpjTGyOSpPTVBN2YwcP9G.S_PqkLcnDGBWgfWblhlEZqxZ_7R8JrHB8CHI9ihyA_yST3r1.uAkQSKLUso9BZzkbIv5jQ2vY2S.Kh48WzxBRnIqWkIeKTM.6ZcXNq8oZOB2YbgQrqwJdQtK8zmoeGs8YQYcKFqo6_yBecjE_DfU7LG0keyoY2hhXeDLa7ITxlfSx5pRju5Hskdu9P_Fie8hCAUylIBPOrd7KN9Z3UnmjN8xovyau5CVN_BaUeeIG0bzOS_vz0hK8R8aDrd64ZRhmQXYwWVlfai0_DQTFgs9Xc2VhvhHEFYHXb6NvR9Vr4VicwoiwbzSm_Ln2AsMctVWFN6hoEv0I4s5O8R8FroBtOfZVf91lHizjL.NpeXvB8.LEu5Lx80640FsLQYx4eLrM8w4f3KyY0k_r.twoTGGWDV7o1emJ9yNkOg4Sloqj6PyUY7EK7UmOxZQhc4ZSIgqQrdY4lXUdMfgI3J7OH0o4ysQwwfgZ5hrt23Nc5oFrQPnptLlqaL4m4dEU_3iqNSw0nyl0HZ.ubWNaUMUZVa0TK9w3AcWIft536SR8G1dleLhvsPqD44z23nI7DpWRX2ZjbEH8jeZzaF0.wRuzNq.0THwQRRqAjpx_Y4xYU1ogLfESIBH6vtrxBXid831N4BXwzON.AfwrfUWzaC5tYrf_c8rZlszltjuksPTdroQIwfjA23FG0irInEpiWiUsr8vnAqCTCYcVkybur5JvEsY_d2keKfVc2v6y45qTyYRWur.NyYPNu_daIOIncmgcPAAQlVwgotrR8AOs3vALJgXU2PRm04AI4_jpI4NrsvZEyyYjv4XG7q2Dvovs8Abki44t.sY.UArbXiAAHxHiWtbKN_cAKZhdn9pto1gcL.xW4bSVUlTyMz6nI9peEsLOUDwaz8Aq.u5U8boeMJtP7z5lTGBbfIBN_kfRvyBVRzxWhhe.oi9FnKjWCTnx8u8ftNJvf2ypD_3tiuA11u9swEuCCCXAGJTw8Xe1B2OjR0KjXyHCJd8SoU.R7Bl5h9PzMdlqmRmbFw7tNnGtbI.RNyXTJb2AxrbXiU1_BmYwZq5Jj3R5l2necO8UlHCwbTis6h0lAWZ1NBI5Hmntkn1lX5rPxz1ucc1TOh.Q0VyaIRyFZG7jG.hy0i.WSqU5O__2.gXWbThvs7xEEPO8l.hWrw57b9fKM515RmZj_jS5ljZ43xWiLbcTX0M.5GMbMRPqb"};var cpo = document.createElement('script');cpo.src = '/cdn-cgi/challenge-platform/h/b/orchestrate/chl_page/v1?ray=8e946af9fe0d919c';window._cf_chl_opt.cOgUHash = location.hash === '' && location.href.indexOf('#') !== -1 ? '#' : location.hash;window._cf_chl_opt.cOgUQuery = location.search === '' && location.href.slice(0, location.href.length - window._cf_chl_opt.cOgUHash.length).indexOf('?') !== -1 ? '?' : location.search;if (window.history && window.history.replaceState) {var ogU = location.pathname + window._cf_chl_opt.cOgUQuery + window._cf_chl_opt.cOgUHash;history.replaceState(null, null, "\/biochemj\/article\/70\/4\/660\/51446\/Toxopyrimidine-phosphate-as-an-inhibitor-of?__cf_chl_rt_tk=GJyPxW8AsClZn3FJureRJ47W2ULImRwU1ri46ctK9RQ-1732734621-1.0.1.1-8ZItR1ZVOSjdB4AO_SxsshheO298y1htfiQ0988Ouqg" + window._cf_chl_opt.cOgUHash);cpo.onload = function() {history.replaceState(null, null, ogU);}}document.getElementsByTagName('head')[0].appendChild(cpo);}());</script></body></html>